文献速递关节外科

围手术期骨科手术之家:优化全关节置换术候选患者并预防再入院

Perioperative Orthopedic Surgical Home: Optimizing Total Joint Arthroplasty Candidates and Preventing Readmission.
PubMed 文献 · J Arthroplasty · 2019-01-18

结果显示,评分3至5分的POSH患者30天和90天再入院率低于非POSH组,出院至急性后期护理机构的比例也更低,但住院时间和感染率无差异。

要点

  • 全关节置换术前采用再入院风险评估工具筛查,评分≥3分者被视为高风险并纳入分析。
  • 在评分3至5分的患者中,POSH组30天再入院率为1.6%,低于非POSH组的5.3%(P = .03)。
  • POSH组出院至急性后期护理机构的比例为15.3%,低于非POSH组的23.4%(P = .01)。

核心结论

  • 手术前识别并医学优化合并症可能提升全关节置换术候选患者的诊疗价值。
  • 对高风险全关节置换术候选患者采用标准化多学科医学优化方法,可能改善患者参与度和围手术期结局,同时降低全关节置换术相关费用。

研究设计与样本

  • 回顾性队列研究,证据等级为III级。
  • 2014年1月至2016年12月期间接受全关节置换术的4188例患者接受再入院风险评估工具评分回顾性筛查。
  • 患者分为两组:入组围手术期骨科手术之家(POSH)项目组216例,未入组继续手术的非POSH组978例。

主要发现

  • 再入院风险评估工具评分为3至5分的患者中,POSH组30天再入院率为1.6%,非POSH组为5.3%(P = .03)。
  • 再入院风险评估工具评分为3至5分的患者中,POSH组90天再入院率为3.2%,非POSH组为7.4%(P < .05)。
  • POSH组中15.3%的医学优化患者出院至急性后期护理机构,非POSH组为23.4%(P = .01)。
  • 两组住院时间和感染率无差异。
  • 非POSH组接受医疗保险的全关节置换术患者90天诊疗周期费用高出14.9%,若发生再入院则费用高出32.6%。

关键数值与推荐

  • 再入院风险评估工具评分≥3分被用作术前高风险筛查标准。
  • POSH组与非POSH组的30天再入院率分别为1.6%和5.3%(P = .03)。
  • POSH组与非POSH组的90天再入院率分别为3.2%和7.4%(P < .05)。
  • POSH组与非POSH组出院至急性后期护理机构的比例分别为15.3%和23.4%(P = .01)。

临床怎么用

  • 原文结论指出,手术前识别并医学优化合并症可能提升全关节置换术候选患者的诊疗价值。
  • 原文结论指出,对高风险全关节置换术候选患者采用标准化多学科医学优化方法,可能改善患者参与度和围手术期结局,同时降低全关节置换术相关费用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is well recognized that unplanned readmissions following total joint arthroplasty (TJA) are more prevalent in patients with comorbidities. However, few investigators have delayed surgery and medically optimized patients prior to surgery. In its current form, the Perioperative Orthopedic Surgical Home (POSH) is a surgeon-led screening and optimization initiative targeting 8 common modifiable comorbidities. METHODS: A total of 4188 patients who underwent TJA between January 2014 and December 2016 were retrospectively screened by the Readmission Risk Assessment tool (RRAT) score. one thousand one hundred and ninety four subjects had a preoperative RRAT score ≥3 and were eligible for inclusion. Patients were then separated into 2 cohorts based on whether they were enrolled into the POSH initiative (POSH; n = 216) or continued with surgery (non-POSH; n = 978) despite their risk. RESULTS: Since the implementation of the POSH initiative, patients with RRAT scores ranging from 3 to 5 have experienced lower 30-day (1.6% vs 5.3%, P = .03) and 90-day (3.2% vs 7.4%, P < .05) readmission rates when compared to the non-POSH cohort. Only 15.3% of medically optimized patients enrolled in the POSH initiative were discharged to a post-acute care facility, whereas 23.4% of non-POSH patients were discharged to a post-acute care facility (P = .01). There were no differences in length of stay and infection rates between the 2 cohorts. Moreover, 90-day episode-of-care costs were 14.9% greater among non-POSH Medicare TJA recipients and 32.6% higher if a readmission occurred. CONCLUSION: The identification and medical optimization of comorbidities prior to surgical intervention may enhance the value of care TJA candidates receive. A standardized multidisciplinary approach to the medical optimization of high-risk TJA candidates may improve patient engagement and perioperative outcomes, while reducing cost associated with TJA. LEVEL OF EVIDENCE: Level III, Retrospective Cohort Study.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Kim KY, Anoushiravani AA, Chen KK, et al. Perioperative Orthopedic Surgical Home: Optimizing Total Joint Arthroplasty Candidates and Preventing Readmission. J Arthroplasty. 2019. PMID: 30745217. doi:10.1016/j.arth.2019.01.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。